These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 33341150)

  • 1. Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study.
    Jabbari E; Koga S; Valentino RR; Reynolds RH; Ferrari R; Tan MMX; Rowe JB; Dalgard CL; Scholz SW; Dickson DW; Warner TT; Revesz T; Höglinger GU; Ross OA; Ryten M; Hardy J; Shoai M; Morris HR;
    Lancet Neurol; 2021 Feb; 20(2):107-116. PubMed ID: 33341150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study.
    Trinh J; Gustavsson EK; Vilariño-Güell C; Bortnick S; Latourelle J; McKenzie MB; Tu CS; Nosova E; Khinda J; Milnerwood A; Lesage S; Brice A; Tazir M; Aasly JO; Parkkinen L; Haytural H; Foroud T; Myers RH; Sassi SB; Hentati E; Nabli F; Farhat E; Amouri R; Hentati F; Farrer MJ
    Lancet Neurol; 2016 Nov; 15(12):1248-1256. PubMed ID: 27692902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration.
    Sanchez-Contreras M; Heckman MG; Tacik P; Diehl N; Brown PH; Soto-Ortolaza AI; Christopher EA; Walton RL; Ross OA; Golbe LI; Graff-Radford N; Wszolek ZK; Dickson DW; Rademakers R
    Mov Disord; 2017 Jan; 32(1):115-123. PubMed ID: 27709685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of Progressive Supranuclear Palsy: A Review.
    Wen Y; Zhou Y; Jiao B; Shen L
    J Parkinsons Dis; 2021; 11(1):93-105. PubMed ID: 33104043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine-mapping of the non-coding variation driving the Caucasian LRRK2 GWAS signal in Parkinson's disease.
    Heckman MG; Labbé C; Kolicheski AL; Soto-Beasley AI; Walton RL; Valentino RR; Brennan ER; Johnson PW; Baheti S; Sarangi V; Ren Y; Uitti RJ; Wszolek ZK; Ross OA
    Parkinsonism Relat Disord; 2021 Feb; 83():22-30. PubMed ID: 33454605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy.
    Ferrari R; Ryten M; Simone R; Trabzuni D; Nicolaou N; Hondhamuni G; Ramasamy A; Vandrovcova J; ; Weale ME; Lees AJ; Momeni P; Hardy J; de Silva R
    Neurobiol Aging; 2014 Jun; 35(6):1514.e1-12. PubMed ID: 24503276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes.
    Farrell K; Humphrey J; Chang T; Zhao Y; Leung YY; Kuksa PP; Patil V; Lee WP; Kuzma AB; Valladares O; Cantwell LB; Wang H; Ravi A; De Sanctis C; Han N; Christie TD; Afzal R; Kandoi S; Whitney K; Krassner MM; Ressler H; Kim S; Dangoor D; Iida MA; Casella A; Walker RH; Nirenberg MJ; Renton AE; Babrowicz B; Coppola G; Raj T; Höglinger GU; Müller U; Golbe LI; Morris HR; Hardy J; Revesz T; Warner TT; Jaunmuktane Z; Mok KY; Rademakers R; Dickson DW; Ross OA; Wang LS; Goate A; Schellenberg G; Geschwind DH; ; Crary JF; Naj A
    Nat Commun; 2024 Sep; 15(1):7880. PubMed ID: 39251599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype.
    Jabbari E; Woodside J; Tan MMX; Shoai M; Pittman A; Ferrari R; Mok KY; Zhang D; Reynolds RH; de Silva R; Grimm MJ; Respondek G; Müller U; Al-Sarraj S; Gentleman SM; Lees AJ; Warner TT; Hardy J; Revesz T; Höglinger GU; Holton JL; Ryten M; Morris HR
    Ann Neurol; 2018 Oct; 84(4):485-496. PubMed ID: 30066433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.
    Chen JA; Chen Z; Won H; Huang AY; Lowe JK; Wojta K; Yokoyama JS; Bensimon G; Leigh PN; Payan C; Shatunov A; Jones AR; Lewis CM; Deloukas P; Amouyel P; Tzourio C; Dartigues JF; Ludolph A; Boxer AL; Bronstein JM; Al-Chalabi A; Geschwind DH; Coppola G
    Mol Neurodegener; 2018 Aug; 13(1):41. PubMed ID: 30089514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy.
    Wang H; Chang TS; Dombroski BA; Cheng PL; Patil V; Valiente-Banuet L; Farrell K; Mclean C; Molina-Porcel L; Rajput A; De Deyn PP; Le Bastard N; Gearing M; Kaat LD; Van Swieten JC; Dopper E; Ghetti BF; Newell KL; Troakes C; de Yébenes JG; Rábano-Gutierrez A; Meller T; Oertel WH; Respondek G; Stamelou M; Arzberger T; Roeber S; Müller U; Hopfner F; Pastor P; Brice A; Durr A; Le Ber I; Beach TG; Serrano GE; Hazrati LN; Litvan I; Rademakers R; Ross OA; Galasko D; Boxer AL; Miller BL; Seeley WW; Van Deerlin VM; Lee EB; White CL; Morris H; de Silva R; Crary JF; Goate AM; Friedman JS; Leung YY; Coppola G; Naj AC; Wang LS; ; Dalgard C; Dickson DW; Höglinger GU; Schellenberg GD; Geschwind DH; Lee WP
    Mol Neurodegener; 2024 Aug; 19(1):61. PubMed ID: 39152475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci.
    Sanchez-Contreras MY; Kouri N; Cook CN; Serie DJ; Heckman MG; Finch NA; Caselli RJ; Uitti RJ; Wszolek ZK; Graff-Radford N; Petrucelli L; Wang LS; Schellenberg GD; Dickson DW; Rademakers R; Ross OA
    Mol Neurodegener; 2018 Jul; 13(1):37. PubMed ID: 29986742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for LRRK2 R1441 mutations in a cohort of PSP patients from Germany.
    Madzar D; Schulte C; Gasser T
    Eur J Neurol; 2009 Nov; 16(11):1230-2. PubMed ID: 19538213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.
    Gustavsson EK; Follett J; Trinh J; Barodia SK; Real R; Liu Z; Grant-Peters M; Fox JD; Appel-Cresswell S; Stoessl AJ; Rajput A; Rajput AH; Auer R; Tilney R; Sturm M; Haack TB; Lesage S; Tesson C; Brice A; Vilariño-Güell C; Ryten M; Goldberg MS; West AB; Hu MT; Morris HR; Sharma M; Gan-Or Z; Samanci B; Lis P; Periñan MT; Amouri R; Ben Sassi S; Hentati F; ; Tonelli F; Alessi DR; Farrer MJ
    Lancet Neurol; 2024 Jun; 23(6):603-614. PubMed ID: 38614108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy.
    Chen Z; Chen JA; Shatunov A; Jones AR; Kravitz SN; Huang AY; Lawrence L; Lowe JK; Lewis CM; Payan CAM; Lieb W; Franke A; Deloukas P; Amouyel P; Tzourio C; Dartigues JF; ; Ludolph A; Bensimon G; Leigh PN; Bronstein JM; Coppola G; Geschwind DH; Al-Chalabi A
    Mov Disord; 2019 Jul; 34(7):1049-1059. PubMed ID: 31059154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Genetic Variants in Progressive Supranuclear Palsy in Southeast Asia.
    Ng ASL; Tan AH; Tan YJ; Lim JL; Lian MM; Dy Closas AM; Ahmad-Annuar A; Viswanathan S; Chia YK; Foo JN; Lim WK; Tan EK; Lim SY
    Mov Disord; 2024 Oct; 39(10):1829-1842. PubMed ID: 39149795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
    Noth I; Zhang Y; Ma SF; Flores C; Barber M; Huang Y; Broderick SM; Wade MS; Hysi P; Scuirba J; Richards TJ; Juan-Guardela BM; Vij R; Han MK; Martinez FJ; Kossen K; Seiwert SD; Christie JD; Nicolae D; Kaminski N; Garcia JGN
    Lancet Respir Med; 2013 Jun; 1(4):309-317. PubMed ID: 24429156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease.
    Tan EK; Skipper L; Chua E; Wong MC; Pavanni R; Bonnard C; Kolatkar P; Liu JJ
    Mov Disord; 2006 Jul; 21(7):997-1001. PubMed ID: 16602113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent trait modeling of tau neuropathology in progressive supranuclear palsy.
    Kouri N; Murray ME; Reddy JS; Serie DJ; Soto-Beasley A; Allen M; Carrasquillo MM; Wang X; Castanedes MC; Baker MC; Rademakers R; Uitti RJ; Graff-Radford NR; Wszolek ZK; Schellenberg GD; Crook JE; Ertekin-Taner N; Ross OA; Dickson DW
    Acta Neuropathol; 2021 May; 141(5):667-680. PubMed ID: 33635380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.
    Höglinger GU; Melhem NM; Dickson DW; Sleiman PM; Wang LS; Klei L; Rademakers R; de Silva R; Litvan I; Riley DE; van Swieten JC; Heutink P; Wszolek ZK; Uitti RJ; Vandrovcova J; Hurtig HI; Gross RG; Maetzler W; Goldwurm S; Tolosa E; Borroni B; Pastor P; ; Cantwell LB; Han MR; Dillman A; van der Brug MP; Gibbs JR; Cookson MR; Hernandez DG; Singleton AB; Farrer MJ; Yu CE; Golbe LI; Revesz T; Hardy J; Lees AJ; Devlin B; Hakonarson H; Müller U; Schellenberg GD
    Nat Genet; 2011 Jun; 43(7):699-705. PubMed ID: 21685912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study.
    Rizig M; Bandres-Ciga S; Makarious MB; Ojo OO; Crea PW; Abiodun OV; Levine KS; Abubakar SA; Achoru CO; Vitale D; Adeniji OA; Agabi OP; Koretsky MJ; Agulanna U; Hall DA; Akinyemi RO; Xie T; Ali MW; Shamim EA; Ani-Osheku I; Padmanaban M; Arigbodi OM; Standaert DG; Bello AH; Dean MN; Erameh CO; Elsayed I; Farombi TH; Okunoye O; Fawale MB; Billingsley KJ; Imarhiagbe FA; Jerez PA; Iwuozo EU; Baker B; Komolafe MA; Malik L; Nwani PO; Daida K; Nwazor EO; Miano-Burkhardt A; Nyandaiti YW; Fang ZH; Obiabo YO; Kluss JH; Odeniyi OA; Hernandez DG; Odiase FE; Tayebi N; Ojini FI; Sidranksy E; Onwuegbuzie GA; D'Souza AM; Osaigbovo GO; Berhe B; Osemwegie N; Reed X; Oshinaike OO; Leonard HL; Otubogun FM; Alvarado CX; Oyakhire SI; Ozomma SI; Samuel SC; Taiwo FT; Wahab KW; Zubair YA; Iwaki H; Kim JJ; Morris HR; Hardy J; Nalls MA; Heilbron K; Norcliffe-Kaufmann L; ; ; ; ; Blauwendraat C; Houlden H; Singleton A; Okubadejo NU;
    Lancet Neurol; 2023 Nov; 22(11):1015-1025. PubMed ID: 37633302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.